Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)
China · Delayed Price · Currency is CNY 6.38
-0.50 (-7.27%)
Jul 29, 2026, 3:00 PM CST
SHA:603567 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 509.95 | 797.34 | 2,704 | 3,138 | 4,214 | 4,127 |
Revenue Growth | -75.19% | -70.51% | -13.84% | -25.53% | 2.12% | 21.24% |
Gross Profit Gross Profit Growth | -743.54 | -393.5 | 1,370 | 1,292 | 675.25 | 1,298 |
Operating Income Operating Income Growth | -1,467 | -1,123 | 602.9 | 185.52 | -216.71 | 270.38 |
Net Income Net Income Growth | -1,622 | -1,367 | 438.22 | 472.74 | 185.44 | 332.1 |
Earnings Per Share EPS Growth | -1.73 | -1.45 | 0.47 | 0.50 | 0.20 | 0.38 |
EPS Growth | - | - | -7.30% | 155.28% | -48.71% | -25.24% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Industry Industry Growth | 446.51 |
Commercial and Medicinal Sales Commercial and Medicinal Sales Growth | 321.96 |
Total Total Growth | 768.47 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 59 | 84.09 | 1,069 | 1,469 | 1,061 | 1,565 |
Total Debt Total Debt Growth | 3,148 | 3,118 | 3,294 | 3,151 | 2,926 | 2,945 |
Net Cash (Debt) Net Cash Growth | -3,089 | -3,034 | -2,225 | -1,682 | -1,865 | -1,380 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3.29 | -3.23 | -2.37 | -1.79 | -1.98 | -1.60 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 652.58 | 322.1 | 164.31 | -478.24 | -326.79 | -433.94 |
Capital Expenditures CapEx Growth | -50.58 | -68.52 | -189.15 | -95.14 | -404.27 | -448.63 |
Free Cash Flow Free Cash Flow Growth | 602 | 253.57 | -24.84 | -573.38 | -731.07 | -882.57 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | -145.81% | -49.35% | 50.67% | 41.18% | 16.02% | 31.45% |
Operating Margin | -287.59% | -140.88% | 22.30% | 5.91% | -5.14% | 6.55% |
Pretax Margin | -380.57% | -204.10% | 19.36% | 15.24% | 7.08% | 11.02% |
Profit Margin | -318.02% | -171.39% | 16.21% | 15.06% | 4.40% | 8.05% |
FCF Margin | 118.05% | 31.80% | -0.92% | -18.27% | -17.35% | -21.39% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.150 | - | 0.150 | 0.200 | 0.028 | 0.106 |
Dividend Per Share Growth | 0% | - | -25.00% | 614.29% | -73.58% | - |
Dividend Yield | 2.33% | - | 1.31% | 1.70% | 0.23% | 0.72% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 24.87 | 24.16 | 64.65 | 43.40 |
Forward PE | - | 18.18 | 18.18 | 18.18 | 18.18 | 36.69 |
P/FCF Ratio | 9.95 | 33.08 | - | - | - | - |
PS Ratio | 11.75 | 10.52 | 4.03 | 3.64 | 2.85 | 3.49 |